glp 1 tamoxifen GLP-1 weight loss drugs are being linked to lower breast cancer risk. Experts are optimistic about a possible breakthrough Sharing some research on GLP-1

20 (S)-ginsenoside rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin

While most people tolerate the medication well, some side effects may occur, though they are typically mild and manageable

Read more from our latest article about advancing autoimmune disease research through biomarker innovation: #AutoimmuneDiseaseResearch #ClinicalResearch #Biomarkers To view or add a comment, sign in Calling for Papers Recent Advances in Rheumatic Diseases and Rheumatoid Arthritis Deadline: 31 March 2026 Rheumatic diseases encompass a broad and heterogeneous group of conditions, including rheumatoid arthritis, connective autoimmune diseases such as systemic lupus erythematosus, psoriatic arthritis, and other autoimmune and inflammatory disorders

Dofitas, Eileen Vizconde

Contraindicado en ciertas condiciones: Informe a su mdico si tiene antecedentes de insuficiencia renal, problemas hepticos o cualquier trastorno metablico antes de iniciar el tratamiento